Amano Keishiro, Hirayama Masahiro, Azuma Eiichi, Iwamoto Shotaro, Keida Yoshitaka, Komada Yoshihiro
Department of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Department of Cell Transplantation, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.
Mediators Inflamm. 2015;2015:747680. doi: 10.1155/2015/747680. Epub 2015 Apr 21.
Natural killer (NK) cells acquire effector function through a licensing process and exert anti-leukemia/tumor effect. However, there is no means to promote a licensing effect of allogeneic NK cells other than cytomegalovirus reactivation-induced licensing in allogeneic hematopoietic stem cell transplantation in human. In mice, a licensing process is mediated by Ly49 receptors which recognize self-major histocompatibility complex class I. The distribution of four Ly49 receptors showed similar pattern in congenic mice, B10, B10.BR, and B10.D2, which have B10 background. Forty Gy-irradiated 2 × 10(6) B10.D2 cells including splenocytes, peripheral blood mononuclear cells in untreated mice, or granulocyte colony-stimulating factor treated mice were injected intraperitoneally into B10 mice. We found that murine NK cells were effectively licensed by intraperitoneal injection of donor neutrophils with its corresponding NK receptor ligand in B10 mice as a recipient and B10.D2 as a donor. Mechanistic studies revealed that NK cells showed the upregulation of intracellular interferon-γ and CD107a expression as markers of NK cell activation. Moreover, enriched neutrophils enhanced licensing effect of NK cells; meanwhile, licensing effect was diminished by depletion of neutrophils. Collectively, injection of neutrophils induced NK cell licensing (activation) via NK receptor ligand interaction.
自然杀伤(NK)细胞通过一种许可过程获得效应功能,并发挥抗白血病/肿瘤作用。然而,在人类同种异体造血干细胞移植中,除了巨细胞病毒再激活诱导的许可外,没有其他方法可以促进同种异体NK细胞的许可效应。在小鼠中,许可过程由识别自身主要组织相容性复合体I类的Ly49受体介导。在具有B10背景的同源小鼠B10、B10.BR和B10.D2中,四种Ly49受体的分布呈现相似模式。将经40 Gy照射的2×10⁶个B10.D2细胞(包括未处理小鼠的脾细胞、外周血单个核细胞或粒细胞集落刺激因子处理的小鼠的细胞)腹腔注射到B10小鼠体内。我们发现,在以B10小鼠为受体、B10.D2为供体的情况下,通过腹腔注射供体中性粒细胞及其相应的NK受体配体,可有效许可小鼠NK细胞。机制研究表明,NK细胞表现出细胞内干扰素-γ和CD107a表达上调,作为NK细胞激活的标志物。此外,富集的中性粒细胞增强了NK细胞的许可效应;同时,中性粒细胞的耗竭会减弱许可效应。总的来说,注射中性粒细胞通过NK受体配体相互作用诱导NK细胞许可(激活)。